Sight Sciences officer plans $220K share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Sight Sciences, Inc. officer Taylor Brenton reported an intended sale of 20,685 common shares, with an aggregate market value of $220,003.59 and an approximate sale date of November 16, 2026. The shares were acquired from the issuer through restricted stock vesting on November 13, 2026, as compensation. The sale includes an amount necessary to cover a tax obligation resulting from settlement of a vested equity award distribution. Brenton also sold 2,988 common shares for gross proceeds of $26,453.37 on October 2, 2026.
Key Figures
Key Terms
Restricted Stock Vesting financial
vested equity award distribution financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does Taylor Brenton's SGHT sale include for taxes?
AI-generated analysis. How Rhea-AI works. Not financial advice.